Global Cell Line Development Market Size study, by Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines), by Product (Equipment, Media and Reagents), by Source (Mammalians) and Regional Forecasts 2021-2027

Global Cell Line Development Market Size study, by Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines), by Product (Equipment, Media and Reagents), by Source (Mammalians) and Regional Forecasts 2021-2027

Global Cell Line Development Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Cell line development is the process by which the cellular machinery is co-opted to manufacture therapeutic biologics or other proteins of interest. Increasing demand for monoclonal antibodies, increase investment in hospital infrastructure has led to the adoption of Cell Line Development across the forecast period. For Instance: As per the IBEF, The hospital industry in India is forecast to increase to Rs. 8.6 trillion (US$ 132.84 billion) by FY22 from Rs. 4 trillion (US$ 61.79 billion) in FY17 at a CAGR of 16–17%. Also, with the increasing risk of pandemic and communicable diseases, the adoption & demand for Cell Line Development is likely to increase the market growth during the forecast period. However, developing stable and authentic cell lines impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Cell Line Development market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to increased demand for monoclonal antibodies, rising vaccine production, and the use of innovative technologies. Whereas, North-America is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies would create lucrative growth prospects for the Cell Line Development market across North America region.

Major market players included in this report are:
Sartorius AG (Germany)
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
Wuxi App Tec, Inc. (China)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Primary Cell Lines
Continuous Cell Lines
Hybridomas
Recombinant Cell Lines
By Product:
Equipment
Media and Reagents
By Source:
Mammalians
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Cell Line Development Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Sartorius AG (Germany)
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
Wuxi App Tec, Inc. (China)